fbpx

Syntaxin enters agreement with SynCo Bio Partners B.V.

Syntaxin enters manufacturing agreement with SynCo Bio Partners B.V. Progresses Acromegaly programme towards clinic.

SynCo_Bio_Release_9_5_2011_(2).pdf

News

The Lundbeck Foundation increases its commitment to IO Biotech
12. January 2021
The Lundbeck Foundation launches 2030 strategy with ambitious goals for grant and commercial activities
22. December 2020
Lundbeck foundation awards grants worth dkk 57 million to bold projects
15. December 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge